期刊文献+

原发性胆汁性肝硬化的免疫学特点及治疗进展 被引量:2

暂未订购
导出
摘要 原发性胆汁性肝硬化(PBC)是一种自身免疫性疾病。一般认为抗线粒体抗体(AMA)及其亚型AMA-M2对PBC检测有一定的特异性,但还存在着一定比例的阴性患者。目前GP210抗体、SP100也被认为是PBC的特异性抗体,但阳性率低。由于PBC要通过病理才能明确诊断,特别是在许多基层医院误诊较多,本文分析了PBC的免疫特点以及常见的误诊原因,可以对该病的诊断提供一定的帮助。
作者 张波 张余芬
出处 《海南医学》 CAS 2011年第7期130-131,共2页 Hainan Medical Journal
基金 无锡市科技局项目(社会发展)(编号:CSZ00951)
  • 相关文献

参考文献19

  • 1Charatcharoenwitthaya P,Lindor KD.Current concepts in the pathogenesis of primary biliarycirrhosis[J].Ann Hepatol,2005,4(3):161-175.
  • 2Yoncyama K,Yamazaki M,Kogo M,et al.Prognostic factors of primary biliary Cirrhosis detected by health screening[J].Minerva Gastroenterol Dietol,2006,52(1):97-105.
  • 3Kim WR,Lindor KD,Locke GR,et al.Epidemiology and natural history of primary biliary cirrhosis in a US community[J].Gastroenterology,2000,119(6):1631 -1636.
  • 4James OF,Bhopal R,Howel D,et al.Primary biliary cirrhosis once rare,now common in the united kingdom[J].Hepatology,1999,30 (2):390-394.
  • 5Lindor KD,Gershwin ME,Poupon R,et al Prinmary bilary cirrhosis[J].Hepatology,2009,50(1):291-308.
  • 6Talwalkar JA,Lindor KD.Primary biliary cirrhosis[J].Lancet,2003,362(9377):53-61.
  • 7Mayo MJ.Portal hypertension in primary biliary cirrhosis:a potentially reversible harbinger of demise[J].Gastroenterology,2008,135(5):1450-1451.
  • 8巫协宁.临床肝胆系病学[M].上海:上海科学技术文献出版社,2002.283.
  • 9Lacerda MA,Ludwig J,Dickson ER,et al.Antimitochondrial antibody-negative primary biliary cirrhosis[J].Am J Gastroenterol,1995,90(1):247-249.
  • 10陈燕,龙波,姚定康,周晔,蒋天舒,谷明莉,陈波,仲人前,邓安梅.原发性胆汁性肝硬化患者外周血T淋巴细胞亚群检测的意义[J].临床检验杂志,2007,25(1):34-35. 被引量:8

二级参考文献17

  • 1何文革,孙永涛,邹爱民.原发性胆汁性肝硬化外周血T细胞亚群及细胞因子的检测[J].胃肠病学和肝病学杂志,2004,13(5):511-513. 被引量:10
  • 2陈其奎,陈海英,王连源,曾志勇,周晓东.2型糖尿病患者发生脂肪肝的独立危险因素分析[J].中华肝脏病杂志,2004,12(7):414-416. 被引量:10
  • 3罗敏.加强对成人晚发自身免疫性糖尿病的研究[J].中华内科杂志,1997,36(3):151-152. 被引量:23
  • 4沈麦琪 沈晓黎 等.复合组织切片技术在测定自身抗体中的应用[J].上海免疫学杂志,1984,4:167-167.
  • 5史济招 贾克明 等.毛细胆管胆汁性肝硬化[J].中华内科杂志,1955,3:190-197.
  • 6Szabo G.Pathogenic interactions between alcohol and hepatitis C[J].Curr Gastroenterol Rep,2003,5 (1):86
  • 7Teli MR,Day CP,Burt AD,et al.Dereterminants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver[J].Lancet,1995,346:987
  • 8Heathcote EJ.Management of primary biliary cirrhosis.The American Association for the Study of Liver Diserses Practice guidelines[J].Hepatology,2000,31 (4):1005-1013.
  • 9Poupon RE,Lindor KD,pares A.et al.Combined analysis of the effect of treatment with ursodeoxycholic acid on histologic progression in primary biliary cirrhosis[J].J Hepatol,2003,39:12-16.
  • 10James O F, Bhopal R, Howel D, et al. Primary biliary cirrhosis once rare, now common in the United Kindom [J ]. Hepatology, 1999,30 : 390-394.

共引文献144

同被引文献45

  • 1李蕴铷.原发性胆汁性肝硬化研究进展[J].中国肝脏病杂志(电子版),2010,2(2):47-50. 被引量:2
  • 2高峰,贾继东.熊去氧胆酸治疗原发性胆汁性肝硬化的研究进展[J].胃肠病学和肝病学杂志,2004,13(5):561-563. 被引量:24
  • 3李峥,毕胜,杨曦,高玉红.抗核抗体谱检测对系统性红斑狼疮的诊断价值[J].云南医药,2005,26(5):400-402. 被引量:8
  • 4韩建华,李永哲,佟大伟,张蜀澜,胡朝军.系统性硬皮病抗核抗体谱的检测分析[J].中国实验诊断学,2007,11(6):756-759. 被引量:5
  • 5Kivity S,Gilburd B,Agmon-Levin N,et al.A novel automated indirect immunofluorescence autoantibody evaluation.Clin Rheumato1,2012,31 (3) 503-509.
  • 6Damoiseaux J G,Tervaert J W.From ANA to ENA:how to proceed?Autoimmun Rev,2006,5 (1):10-17.
  • 7Song L J,Ding F,Liu H X,et al.Analysis of 15 patients with systemic lupus erythematosus manifesting with negative immunofluorescence anti-nuclear antibodies after treatment.Lupus,2012,21 (8):919-924.
  • 8Bizzaro N,Villalta D,Giavarina D,et al.Are anti-nucleosome antibodies a better diagnostic marker than anti-dsDNA antibodies for systemic lupus erythematosus? A systematic review and a study of metanalysis.Autoimmun Rev,2012,12 (2):97-106.
  • 9Hoxha A,Ruffatti A,Grypiotis P,et al.Antinuclear,anti-dsDNA and anti-ENA antibodies in patients affected with rheumatoid arthritis or ankylosing spondylitis during treatment with infliximab.Reumatismo,2006,58 (2):21-26.
  • 10Albon S,Bunn C,Swana G,et al.Performance of a multiplex assay compared to enzyme and precipitation methods for anti-ENA testing in systemic lupus and systemic sclerosis.Immunol Methods,2011,365(1-2):126-131.

引证文献2

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部